MedPath

ontuberculous mycobacterial cervicofacial lymphadenitis in children; diagnostic performance of the Capilia MAC antibody Elisa test and possible portals of entry

Recruiting
Conditions
Nontuberculous mycobacterial cervicofacial lymphadenitis/Atypical mycobacterial head and neck infcection of the lymph nodes
10028440
Registration Number
NL-OMON56039
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
96
Inclusion Criteria

Study group:

• Age between 0-15 years
• High clinical suspicion of NTM cervicofacial lymphadenitis, as defined by
the following factors;
- Cervicofacial lymphadenopathy for a period longer than 3 weeks
- Typical clinical presentation as defined by Penn et al. (2011)
- Negative serologic tests for other kinds of (sub) chronical
lymphadenopathy: Epstein-Barr virus,
cytomegalovirus, Bartonella species, Adenovirus, and toxoplasmosis
- Ultrasonographically, hypoechoic lymph nodes, often with central necrosis,
nodal matting and adjacent soft tissue oedema

Control group:
• Age between 0-15 years
• Indication for surgery under general anesthesia

Exclusion Criteria

Study group:
- Known immunodeficiencies
- Usage of immunosuppressive drugs

Control group:
- Clinical suspicion of NTM cervicofacial lymphadenisis as defined above

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath